december, 2014

15dec8:30 am1:00 pmBoston Life Sciences Summit


Event Details

Beyond the Science – How further innovation creates value

Innovation lies at the heart of Life Sciences companies discovering new targets, mechanisms of action, molecules, diagnostics and devices. As if that weren’t difficult enough, even more challenges lie ahead in reimbursement, adoption, and adherence to name a few.

Even strong life sciences companies in flourishing markets like Boston soon face the double edged sword successful scientific innovation brings: realizing the potential of rapid growth in an increasingly commoditized and reimbursement cautious market place. Our symposium is dedicated to exploring the paths of business innovation both necessary and possible to capture value beyond scientific innovation.

8:30 –   8:45 a.m.      Welcome
8:45 –   9:15 a.m.      Keynote
9:15 – 11:30 a.m.      Program
11:30 – 12:00 p.m.      Q&A
12:00 –   1:00 p.m.      Lunch and networking

Boston Cambridge Marriott
2 Cambridge Center
Cambridge, MA 02142

Speakers will include:
Alexis Borisy, Partner, Third Rock Ventures – Keynote speaker
Adelene Perkins, Chair, President and CEO, Infinity Pharmaceuticals
Jeffrey Burbank, Founder and CEO, NxStage Medical
John Maraganore, Ph.D., CEO, Alnylam Pharmaceuticals
Glenn Muir, Former CFO, Hologic
Kevin Casey, Partner, EY Northeast Region MedTech Leader
Kristin Pothier, Partner and Managing Director, EY Transaction Advisory Services

CPE credits provided


(Monday) 8:30 am - 1:00 pm